Table 1 Antibacterial activity of newly predicted peptide on normal (upper) or drug resistant bacteria (lower).
Bacteria | Gram (+/−) | MIC* (µg/mL) |
|---|---|---|
Streptococcus Faecalis | + | 50 |
Streptococcus pyogenes ATCC 14289 | + | 50 |
Staphylococcus aureus ATCC 6538 | + | 20 |
Bacillus subtilis 168 | + | 16 |
Staphylococcus aureus ATCC 29213 | + | 64 |
Aeromonas hydrophila ATCC 49140 | − | 20 |
Vibrio alginolyticus ATCC 33840 | − | 50 |
Edwardsiella tarda PE210 | − | 10 |
E. cloacae BAA-1143 | − | 32 |
Acinetobacter baumannii ATCC 19606 | − | 10 |
Escherichia coli ATCC 10536 | − | 5 |
Escherichia coli (pathogenic) | − | 5 |
Escherichia coli BL21 (DE3) | − | 8 |
Klebsiella pneumoniae (NDM-1) ATCC BAA-2470 | − | 32 |
Escherichia coli (NDM-1) ATCC BAA-2469 | − | 16 |
NDM-1/BL21 (DE3) | − | 4 |
SHV-1/BL21 (DE3) | − | 4 |
TEM-1/BL21 (DE3) | − | 8 |
MCR-1/BL21 (DE3) | − | 16 |
Methicillin-resistant S. aureus ATCC BAA-41 | + | 32 |
Multidrug-resistant S. aureus ATCC BAA-44 | + | 32 |
Staphylococcus epidermidis ATCC 12228 | + | 4 |
Pseudomonas aeruginosa A | − | 50 |
